Copyright
©The Author(s) 2022.
World J Gastroenterol. Mar 7, 2022; 28(9): 948-960
Published online Mar 7, 2022. doi: 10.3748/wjg.v28.i9.948
Published online Mar 7, 2022. doi: 10.3748/wjg.v28.i9.948
Figure 1 Selection of the study population.
HCCA: Hilar cholangiocarcinoma.
- Citation: Liu ZP, Chen WY, Zhang YQ, Jiang Y, Bai J, Pan Y, Zhong SY, Zhong YP, Chen ZY, Dai HS. Postoperative morbidity adversely impacts oncological prognosis after curative resection for hilar cholangiocarcinoma. World J Gastroenterol 2022; 28(9): 948-960
- URL: https://www.wjgnet.com/1007-9327/full/v28/i9/948.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i9.948